| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $33.3M | +92.9% |
| SG&A Expense | $11.6M | +18.3% |
| Operating Income | -$45.1M | -65.4% |
| Interest Expense | $4.3M | +98.8% |
| Net Income | -$50.3M | -92.7% |
| EPS (Basic) | -$1.55 | -46.2% |
| EPS (Diluted) | -$1.55 | -46.2% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.5M | +4.4% |
| Current Assets | $34.0M | +81.3% |
| Total Assets | $35.1M | +74.5% |
| Current Liabilities | $14.5M | +247.7% |
| Total Liabilities | $19.8M | +20.2% |
| Stockholders' Equity | $15.3M | +317.9% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.3M | -112.0% |
| Investing Cash Flow | -$14.3M | — |
| Financing Cash Flow | $55.4M | +67.2% |